Onnis A, Andreano E, Cassioli C, Finetti F, Della Bella C, Staufer O, et al. SARS-CoV-2 Spike protein suppresses CTL-mediated killing by inhibiting immune synapse assembly. J Exp Med. 2023;220: pubmed publisher

Cheppali S, Dharan R, Katzenelson R, Sorkin R. Supported Natural Membranes on Microspheres for Protein-Protein Interaction Studies. ACS Appl Mater Interfaces. 2022;: pubmed publisher

Ugalde A, Bretones G, Rodr xed guez D, Quesada V, Llorente F, Fern xe1 ndez Delgado R, et al. Autophagy-linked plasma and lysosomal membrane protein PLAC8 is a key host factor for SARS-CoV-2 entry into human cells. EMBO J. 2022;41:e110727 pubmed publisher

Torrens Mas M, Perell xf3 Reus C, Trias Ferrer N, Ibarg xfc en Gonz xe1 lez L, Cresp xed C, Galmes Panades A, et al. GDF15 and ACE2 stratify COVID-19 patients according to severity while ACE2 mutations increase infection susceptibility. Front Cell Infect Microbiol. 2022;12:942951 pubmed publisher

Yip K, Lee K, Ng T, Xu S, Yung K, Qu S, et al. An anti-inflammatory and anti-fibrotic proprietary Chinese medicine nasal spray designated as Allergic Rhinitis Nose Drops (ARND) with potential to prevent SARS-CoV-2 coronavirus infection by targeting RBD (Delta)- angiotensin converting enzyme 2 (AC. Chin Med. 2022;17:88 pubmed publisher

Bartolomé A, Liang J, Wang P, Ho D, Pajvani U. Angiotensin converting enzyme 2 is a novel target of the γ-secretase complex. Sci Rep. 2021;11:9803 pubmed publisher

Yeung M, Teng J, Jia L, Zhang C, Huang C, Cai J, et al. Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system. Cell. 2021;184:2212-2228.e12 pubmed publisher